Yes, BoMRA has indicated that they will continue accepting, evaluating and registering human medicinal products during the COVID-19 lockdown. Submissions and all correspondence may only be sent electronically. Applicants may not submit samples until further notice. Hard copy communications may be collected once BoMRA working hours normalize. Let us know if there is any way Stonebridge Regulatory Consulting can serve you. Schedule a call.
Is BoMRA Accepting Human Medicines Registration Applications During the COVID-19 Lockdown?
